No abstract available
MeSH terms
-
Adult
-
Anticholesteremic Agents / adverse effects*
-
Anticholesteremic Agents / pharmacokinetics
-
Citrus paradisi / adverse effects*
-
Cytochrome P-450 CYP3A
-
Cytochrome P-450 Enzyme Inhibitors
-
Enzyme Inhibitors / adverse effects
-
Enzyme Inhibitors / pharmacology
-
Female
-
Furocoumarins / adverse effects
-
Furocoumarins / pharmacology
-
Humans
-
Hyperlipoproteinemia Type II / drug therapy
-
Inactivation, Metabolic
-
Rhabdomyolysis / chemically induced*
-
Simvastatin / adverse effects*
-
Simvastatin / pharmacokinetics
Substances
-
Anticholesteremic Agents
-
Cytochrome P-450 Enzyme Inhibitors
-
Enzyme Inhibitors
-
Furocoumarins
-
Simvastatin
-
CYP3A protein, human
-
Cytochrome P-450 CYP3A